---
title: 'Impact of DMARD treatment and systemic inflammation on all-cause mortality
  in patients with rheumatoid arthritis and interstitial lung disease: a cohort study
  from the German RABBIT register'
date: '2024-04-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38580343/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240406181050&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Inflammatory biomarkers and absence of DMARD treatment
  were associated with increased risk of mortality in patients with RA-ILD. Non-TNFi
  bDMARDs may confer enhanced therapeutic benefits in patients with ...'
disable_comments: true
---
CONCLUSIONS: Inflammatory biomarkers and absence of DMARD treatment were associated with increased risk of mortality in patients with RA-ILD. Non-TNFi bDMARDs may confer enhanced therapeutic benefits in patients with ...